Cetuximab (C225) is a human IgG1 monoclonal antibody that inhibits epidermal growth factor receptor (EGFR), with a Kd of 0.201 nM for EGFR by SPR. Cetuximab has potent antitumor activity[1].
Molecular Weight:
(145.54 kDa)
Purity:
99.70
CAS Number:
[205923-56-4]
Target:
EGFR,Radionuclide-Drug Conjugates (RDCs)
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
